fluoxetine has been researched along with reserpine in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (33.33) | 18.7374 |
| 1990's | 6 (10.53) | 18.2507 |
| 2000's | 11 (19.30) | 29.6817 |
| 2010's | 17 (29.82) | 24.3611 |
| 2020's | 4 (7.02) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Margalit, D; Segal, M | 1 |
| Bond, A; Neal, H | 1 |
| Fang, VS; Meltzer, HY; Simonovic, M; Stanisic, D | 1 |
| Artaud, F; Bourgoin, S; Glowinski, J; Hamon, M | 1 |
| Frittoli, E; Garattini, S; Gobbi, M; Mennini, T | 1 |
| Anderson, CR; Campbell, G; O'Shea, F; Payne, M | 1 |
| Angus, JA; Wright, CE | 1 |
| Gillespie, DD; Manier, DH; Sulser, F | 1 |
| Kuhn, DM; Wolf, WA; Youdim, MB | 1 |
| Allen, JM; Fairweather, I; Halton, DW; McKay, DM | 1 |
| Fuller, RW | 1 |
| Foley, AJ; Leedham, JA; Pennefather, JN | 1 |
| Poshivalov, VP; Valdman, AV | 1 |
| Jackson, DM; Jenkins, OF | 2 |
| Costa, M; Cuello, AC; Elde, RP; Furness, JB; Steinbusch, HW; Verhofstad, AA | 1 |
| Brownfield, MS; Holzwarth, MA; Sawetawan, C | 1 |
| Bosin, TR; Mais, DE | 1 |
| Bouchal, RL; Martin, LL; Smith, DJ | 1 |
| Kizer, JS; Long, JB; Youngblood, WY | 1 |
| Maj, J; Rogóz, Z; Skuza, G; Sowińska, H | 1 |
| Bastide, P; Coudert, P; Rubat, C; Tronche, P | 1 |
| Azmitia, EC; Gu, XF | 1 |
| Bagdy, E; Harsing, LG; Solyom, S | 1 |
| Barrier, L; Chalon, S; Huguet, F; Page, G; Piriou, A | 1 |
| Jung, JS; Kim, HD; Kim, HS; Kim, KW; Kim, YH; Song, DK; Suh, HW; Woo, RS | 1 |
| Diavolitsis, P; Dringenberg, HC | 1 |
| Jain, NK; Kulkarni, SK; Singh, A | 1 |
| Cozzi, NV; Foley, KF | 1 |
| Barthó, L; Dénes, V; Gábriel, R; Lázár, Z | 1 |
| Dunlop, PC; Johnson, GJ; Leis, LA; Weir, EK | 1 |
| Battaglino, R; Ersoy, U; Fu, J; Joe, M; Sedaghat, L; Späte, U; Stashenko, P | 1 |
| Nagappa, AN; Vijayapandi, P | 1 |
| Hasegawa, R; Ikeda, K; Karasawa, J; Tamura, K; Yamamoto, H; Yamamoto, T; Yasumoto, S | 1 |
| Condron, B; Venton, BJ; Vickrey, TL | 1 |
| Crisp, KM; Grupe, RE; Lobsang, TT; Yang, X | 1 |
| Chi, W; Cui, YL; Dong, TJ; Gao, S; Hu, LM; Liu, LP; Tian, JS | 1 |
| Fan, DS; Guo, L; Ji, CX; Li, W; Liang, ZL; Xu, RM; Zhang, JJ | 1 |
| Cui, YL; Ding, SL; Mao, HP; Qi, XJ; Wang, QS | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Privman Champaloux, E; Pyakurel, P; Venton, BJ | 1 |
| Fernández-Guasti, A; González-Trujano, ME; Hernandez-Leon, A; Martínez, A; Pellicer, F | 1 |
| Calliari, A; Pautassi, RM; Ruiz, P | 1 |
| Blakely, RD; Refai, O | 1 |
| Ahmed-Farid, OA; El Awdan, SA; El-Marasy, SA; Hassan, A; Ogaly, HA | 1 |
| Ahmed, AS; Behl, T; Bhatt, S; Chigurupati, S; Gari, SBV; Sehgal, A; Sharma, N; Singh, S | 1 |
| Altenhofen, S; Bonan, CD; da Silva, JMK; de Melo Martins, GM; Gaspary, KV; Petersen, BD; Rübensam, G; Wiprich, MT | 1 |
| Braida, D; Dellarole, I; Morara, S; Ponzoni, L; Sala, M | 1 |
3 review(s) available for fluoxetine and reserpine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Biochemical pharmacology of the serotonin system.
Topics: Alanine; Brain; Citalopram; Clomipramine; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Neurons; Oximes; p-Chloroamphetamine; Paroxetine; Piperidines; Propylamines; Receptors, Serotonin; Reserpine; Serotonin; Serotonin Antagonists; Synapses; Tetrabenazine; Zimeldine | 1986 |
Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.
Topics: Adenylyl Cyclases; alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Dextroamphetamine; Drug Interactions; Fluoxetine; Humans; Methyltyrosines; Mice; Motor Activity; Nialamide; Nomifensine; Nucleus Accumbens; Rats; Receptors, Dopamine; Reserpine; Stereotyped Behavior | 1985 |
54 other study(ies) available for fluoxetine and reserpine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A pharmacologic study of analgesia produced by stimulation of the nucleus locus coeruleus.
Topics: Adrenergic alpha-Antagonists; Analgesia; Animals; Clonidine; Cyproheptadine; Ditiocarb; Electric Stimulation; Fluoxetine; Hydroxydopamines; Locus Coeruleus; Male; Naloxone; Rats; Reserpine; Self Stimulation | 1979 |
Modification of PGO activity by specific uptake inhibitors fluoxetine, nisoxetine and LR5182.
Topics: 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Bridged Bicyclo Compounds; Bridged-Ring Compounds; Cats; Decerebrate State; Dimethylamines; Electroencephalography; Female; Fenclonine; Fluoxetine; Geniculate Bodies; Male; Occipital Lobe; Phenyl Ethers; Pons; Propylamines; Reserpine; Time Factors | 1979 |
Ketamine as an anesthetic for obtaining plasma for rat prolactin assays.
Topics: 5-Hydroxytryptophan; Animals; Blood Specimen Collection; Catheterization; Drug Interactions; Fluoxetine; Ketamine; Male; Prolactin; Rats; Reserpine | 1978 |
The role of intraneuronal 5-HT and of tryptophan hydroxylase activation in the control of 5-HT synthesis in rat brain slices incubated in K+-enriched medium.
Topics: Animals; Brain Stem; Enzyme Activation; Fluoxetine; In Vitro Techniques; Kinetics; Male; Pargyline; Potassium; Rats; Reserpine; Serotonin; Tryptophan Hydroxylase | 1979 |
Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]serotonin.
Topics: Animals; Calcium; Chromatography, High Pressure Liquid; Fenfluramine; Fluoxetine; Hippocampus; Male; Rats; Reserpine; Serotonin; Serotonin Antagonists; Synaptosomes | 1992 |
The release of neuronal 5-HT from the intestine of a teleost fish, Platycephalus bassensis.
Topics: Animals; Chromatography, High Pressure Liquid; Electric Stimulation; Fishes; Fluoxetine; Hydroxyindoleacetic Acid; Intestinal Mucosa; Neurons; Reserpine; Serotonin; Tetrodotoxin | 1991 |
5-carboxamidotryptamine elicits 5-HT2 and 5-HT3 receptor-mediated cardiovascular responses in the conscious rabbit: evidence for 5-HT release from platelets.
Topics: Animals; Blood Platelets; Dose-Response Relationship, Drug; Female; Fluoxetine; Heart Rate; Hindlimb; Male; Rabbits; Receptors, Serotonin; Reflex; Renal Artery; Reserpine; Serotonin; Serotonin Antagonists | 1989 |
Dual aminergic regulation of central beta adrenoceptors. Effect of "atypical" antidepressants and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Adrenergic beta-Agonists; Animals; Antidepressive Agents; Binding, Competitive; Desipramine; Dihydroalprenolol; Fluoxetine; Male; Mianserin; Models, Biological; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Regression Analysis; Reserpine; Serotonin; Serotonin Antagonists; Tritium | 1989 |
5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats.
Topics: Animals; Behavior, Animal; Brain; Fluoxetine; Hydroxyindoleacetic Acid; Male; Metergoline; p-Chloroamphetamine; Pargyline; Rats; Rats, Inbred Strains; Reserpine; Serotonin | 1985 |
The effects of cholinergic and serotoninergic drugs on motility in vitro of Haplometra cylindracea (Trematoda: Digenea).
Topics: Acetylcholine; Animals; Atropine; Carbachol; Fluoxetine; Methysergide; Movement; Nicotine; Parasympathomimetics; Physostigmine; Rana temporaria; Reserpine; Serotonin; Serotonin Antagonists; Trematoda; Tubocurarine | 1989 |
Some pharmacological actions of nisoxetine, a bicyclic inhibitor of noradrenaline uptake.
Topics: Animals; Bradykinin; Carbachol; Desipramine; Fluoxetine; Guinea Pigs; Histamine; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neurons; Norepinephrine; Propylamines; Rats; Receptors, Adrenergic, alpha; Reserpine; Vas Deferens; Xylazine | 1985 |
Pharmaco-ethological analysis of antidepressant drug effects.
Topics: Aggression; Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Fluoxetine; Imipramine; Iproniazid; Male; Mice; Motor Activity; Reserpine; Social Behavior; Trazodone | 1986 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
Neurons with 5-hydroxytryptamine-like immunoreactivity in the enteric nervous system: their visualization and reactions to drug treatment.
Topics: 5,7-Dihydroxytryptamine; Animals; Desipramine; Digestive System; Fenclonine; Fluorescent Antibody Technique; Fluoxetine; Guinea Pigs; Hydroxydopamines; Mice; Myenteric Plexus; Oxidopamine; Rabbits; Rats; Reserpine; Serotonin; Submucous Plexus | 1982 |
Serotonin-immunoreactivity in the adrenal medulla: distribution and response to pharmacological manipulation.
Topics: Adrenal Medulla; Animals; Fluoxetine; Immunoenzyme Techniques; Male; p-Chloroamphetamine; Pargyline; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Tryptophan | 1984 |
A role for serotonin in alpha-naphthylthiourea-induced pulmonary edema.
Topics: Animals; Blood Platelets; Clorgyline; Drug Interactions; Fluoxetine; Ketanserin; Lung; Male; Mice; Piperidines; Pulmonary Edema; Reserpine; Serotonin; Serotonin Antagonists; Thiourea; Thrombocytopenia | 1984 |
Ketamine inhibits serotonin uptake in vivo.
Topics: Animals; Brain; Fenclonine; Fluoxetine; Ketamine; Male; Nialamide; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reserpine; Serotonin; Spiperone | 1982 |
Regional differences in the response of serotonergic neurons in rat CNS to drugs.
Topics: 5-Hydroxytryptophan; Animals; Brain; Fluoxetine; Male; Methiothepin; Methoxydimethyltryptamines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reserpine; Serotonin; Tryptophan | 1983 |
The effect of selective inhibitors of noradrenaline and serotonin uptake on reserpine- and apomorphine induced hypothermia in mice.
Topics: Animals; Apomorphine; Body Temperature; Citalopram; Desipramine; Fluoxetine; Male; Maprotiline; Mice; Norepinephrine; Propylamines; Reserpine; Serotonin Antagonists | 1983 |
Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
Topics: 5-Hydroxytryptophan; Analgesia; Animals; Antidepressive Agents; Apomorphine; Behavior, Animal; Blepharoptosis; Citalopram; Clomipramine; Drug Interactions; Fluoxetine; Hypothermia; Imipramine; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Models, Molecular; Motor Activity; Naloxone; Piperazines; Pyridazines; Reserpine; Structure-Activity Relationship; Swimming; Trazodone; Yohimbine | 1995 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Feedback stimulation of somatodendritic serotonin release: a 5-HT3 receptor-mediated effect in the raphe nuclei of the rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dendrites; Electric Stimulation; Feedback; Fluoxetine; In Vitro Techniques; Male; Neural Pathways; Ondansetron; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1998 |
Characterization of both dopamine uptake systems in rat striatal slices by specific pharmacological tools.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; In Vitro Techniques; Male; Motor Activity; Norepinephrine; Nortropanes; Oxidopamine; Piperazines; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Tetrabenazine | 1998 |
Characterization of antidepressant-like effects of p-synephrine stereoisomers.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Anesthetics, Local; Animals; Antidepressive Agents; Cerebral Cortex; Fluoxetine; Hindlimb Suspension; Hypothermia; In Vitro Techniques; Male; Norepinephrine; Rats; Rats, Sprague-Dawley; Reserpine; Stereoisomerism; Swimming; Synephrine; Tetrodotoxin; Tritium | 2001 |
Electroencephalographic activation by fluoxetine in rats: role of 5-HT(1A) receptors and enhancement of concurrent acetylcholinesterase inhibitor treatment.
Topics: Alpha Rhythm; Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Data Collection; Electroencephalography; Fluoxetine; Male; Muscarinic Antagonists; Piperazines; Pyridines; Rats; Rats, Long-Evans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reserpine; Scopolamine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Tacrine | 2002 |
Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors.
Topics: Animals; Antidepressive Agents, Tricyclic; Cyclooxygenase Inhibitors; Desipramine; Enterotoxins; Female; Fluoxetine; Lactones; Lipopolysaccharides; Male; Mice; Motor Activity; Naproxen; Reserpine; Selective Serotonin Reuptake Inhibitors; Sulfonamides; Sulfones; Swimming | 2001 |
Rapid and efficient method for suspending cells for neurotransmitter uptake assays.
Topics: Adrenergic Uptake Inhibitors; Biological Transport; Blood Platelets; Cell Separation; Fluoxetine; Free Radical Scavengers; Humans; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Tritium | 2002 |
Serotonin in the rabbit ileum: localization, uptake, and effect on motility.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Free Radical Scavengers; Gastrointestinal Motility; Ileum; Immunoenzyme Techniques; Male; Muscle Contraction; Myenteric Plexus; Rabbits; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2003 |
The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Topics: Appetite Depressants; Blood Platelets; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Norfenfluramine; Phentermine; Reserpine; Secretory Vesicles; Selective Serotonin Reuptake Inhibitors; Serotonin | 2003 |
Serotonin regulates osteoclast differentiation through its transporter.
Topics: Animals; Bone Marrow Cells; Carrier Proteins; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Fluoxetine; Macrophages; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; NF-kappa B; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Receptors, Serotonin; Recombinant Proteins; Reserpine; RNA, Messenger; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2004 |
Biphasic effects of losartan potassium on immobility in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Freezing Reaction, Cataleptic; Losartan; Male; Mice; Mice, Inbred Strains; Nortriptyline; Receptor, Angiotensin, Type 2; Reserpine; Swimming | 2005 |
Inhibitory effect of selective serotonin reuptake inhibitors on the vesicular monoamine transporter 2.
Topics: Animals; Dopamine; Fluoxetine; Fluvoxamine; Haloperidol; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Rats; Rats, Wistar; Reserpine; Selective Serotonin Reuptake Inhibitors; Synaptic Vesicles; Vesicular Monoamine Transport Proteins | 2009 |
Detection of endogenous dopamine changes in Drosophila melanogaster using fast-scan cyclic voltammetry.
Topics: Animals; Animals, Genetically Modified; Central Nervous System; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Fluoxetine; Hydrazines; Microelectrodes; Reserpine | 2009 |
Biogenic amines modulate pulse rate in the dorsal blood vessel of Lumbriculus variegatus.
Topics: 5-Methoxytryptamine; Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Blood Vessels; Clozapine; Cyproheptadine; Drug Antagonism; Fluoxetine; Heart Rate; Imines; Octopamine; Oligochaeta; Reserpine; Serotonin; Theophylline | 2010 |
Antidepressant-like effect of genipin in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Blepharoptosis; Depression; Disease Models, Animal; Fluoxetine; Hindlimb Suspension; Hippocampus; Hypothermia; Iridoid Glycosides; Iridoids; Male; Mice; Mice, Inbred ICR; Motor Activity; Reserpine | 2010 |
Evaluation of the anti-ulcerogenic activity of the antidepressants duloxetine, amitriptyline, fluoxetine and mirtazapine in different models of experimental gastric ulcer in rats.
Topics: Amitriptyline; Animals; Anti-Ulcer Agents; Antidepressive Agents; Disease Models, Animal; Duloxetine Hydrochloride; Fluoxetine; Immersion; Indomethacin; Male; Mianserin; Mirtazapine; Rats; Rats, Sprague-Dawley; Reserpine; Restraint, Physical; Stomach Ulcer; Stress, Psychological; Thiophenes; Water | 2012 |
Antidepressant-like effect of ethanol extract from Zuojin Pill, containing two herbal drugs of Rhizoma Coptidis and Fructus Evodiae, is explained by modulating the monoaminergic neurotransmitter system in mice.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Behavior, Animal; Coptis; Corpus Striatum; Depression; Dopamine; Drugs, Chinese Herbal; Ethanol; Evodia; Fluoxetine; Hippocampus; Hypothermia; Male; Mice; Mice, Inbred ICR; Motor Activity; Neurotransmitter Agents; Phytotherapy; Random Allocation; Reserpine; Rhizome; Serotonin | 2013 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Fast-Scan Cyclic Voltammetry (FSCV) Detection of Endogenous Octopamine in Drosophila melanogaster Ventral Nerve Cord.
Topics: Acetaldehyde Dehydrogenase Inhibitors; Adrenergic Uptake Inhibitors; Animals; Animals, Genetically Modified; Central Nervous System; Disulfiram; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Drosophila Proteins; Electrochemical Techniques; Fluoxetine; Gene Expression Regulation; Light; Neurons; Octopamine; Receptors, Purinergic P2X2; Reserpine; Rhodopsin; Transcription Factors; Tyrosine Decarboxylase | 2016 |
Sleep architecture is altered in the reserpine-induced fibromyalgia model in ovariectomized rats.
Topics: Animals; Disease Models, Animal; Female; Fibromyalgia; Fluoxetine; Hyperalgesia; Ovariectomy; Pain; Polysomnography; Rats; Reserpine; Sleep; Sleep Stages; Sleep Wake Disorders | 2019 |
Reserpine-induced depression is associated in female, but not in male, adolescent rats with heightened, fluoxetine-sensitive, ethanol consumption.
Topics: Alcohol Drinking; Animals; Depression; Dopamine; Ethanol; Female; Fluoxetine; Male; Rats; Rats, Wistar; Reserpine; Risk-Taking; Social Behavior; Stress, Psychological | 2018 |
Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.
Topics: Animals; Animals, Genetically Modified; Antipsychotic Agents; Azaperone; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dopamine; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Reserpine; Signal Transduction | 2019 |
Anti-depressant effect of cerebrolysin in reserpine-induced depression in rats: Behavioral, biochemical, molecular and immunohistochemical evidence.
Topics: Amino Acids; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Cyclic AMP Response Element-Binding Protein; Depression; Disease Models, Animal; Dopamine; Fluoxetine; Hippocampus; Inflammation; Male; Neurogenesis; NF-kappa B; Oxidative Stress; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Reserpine; Serotonin; Signal Transduction | 2021 |
Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Bixaceae; Depression; Fluoxetine; Imipramine; Mice; Motor Activity; Plant Extracts; Rats; Reserpine | 2022 |
Physical exercise prevents behavioral alterations in a reserpine-treated zebrafish: A putative depression model.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Behavior, Animal; COVID-19; Depression; Depressive Disorder, Major; Dopamine; Exercise; Fluoxetine; Humans; Pandemics; Reserpine; Serotonin; Zebrafish | 2022 |
Fluoxetine rescues the depressive-like behaviour induced by reserpine and the altered emotional behaviour induced by nicotine withdrawal in zebrafish: Involvement of tyrosine hydroxylase.
Topics: Anhedonia; Animals; Calcitonin Gene-Related Peptide; Fluoxetine; Nicotine; Reserpine; Substance Withdrawal Syndrome; Tyrosine 3-Monooxygenase; Zebrafish | 2023 |